Seaman Robert W, Collins Gregory T
Department of Pharmacology, The University of Texas Health Science Center at San Antonio, San Antonio, TX, United States.
South Texas Veterans Health Care System, San Antonio, TX, United States.
Front Pharmacol. 2021 May 21;12:691700. doi: 10.3389/fphar.2021.691700. eCollection 2021.
Recent estimates suggest increased popularity of the concurrent use of opioids and stimulants, with over 50% of treatment-seeking opioid users reporting regular stimulant use. The goal of the current study was to determine how opioid dependence and withdrawal affect the reinforcing effects of fentanyl, cocaine, and methamphetamine. Male Sprague-Dawley rats were allowed to self-administer fentanyl under a progressive ratio (PR) schedule of reinforcement. Baseline evaluations of reinforcing effectiveness of fentanyl, cocaine, and methamphetamine were determined. Opioid dependence was then established by administering escalating doses of morphine (10-40 mg/kg) twice-daily for four days and subsequently maintained by once-daily injections of 40 mg/kg morphine. To evaluate the impact of opioid dependence and withdrawal on the self-administration of fentanyl, cocaine, and methamphetamine, sessions occurred either 12 or 20 h after the morphine, respectively. During opioid withdrawal, the fentanyl dose-response curve was shifted rightward with an increase in maximal effectiveness, whereas it was shifted rightward with a reduction in maximal effectiveness when evaluated in rats currently dependent on opioids, relative to baseline. The reinforcing effects of cocaine and methamphetamine were unchanged by either condition. The current studies provide direct evidence that the reinforcing effects of fentanyl are increased in opioid-withdrawn rats and reduced in opioid-dependent rats, relative to rats that are not physically dependent on opioids. These findings suggest that motivations to use opioids are dependent on the state of the individual whereas stimulants retain their reinforcing effects regardless of whether the individual is in an opioid-dependent or withdrawn state.
近期估计表明,阿片类药物和兴奋剂同时使用的情况日益普遍,超过50%寻求治疗的阿片类药物使用者报告有规律地使用兴奋剂。本研究的目的是确定阿片类药物依赖和戒断如何影响芬太尼、可卡因和甲基苯丙胺的强化作用。雄性Sprague-Dawley大鼠在渐进比率(PR)强化程序下被允许自行给药芬太尼。确定了芬太尼、可卡因和甲基苯丙胺强化效果的基线评估。然后通过每天两次给予递增剂量的吗啡(10 - 40毫克/千克),持续四天来建立阿片类药物依赖,随后通过每天一次注射40毫克/千克吗啡来维持。为了评估阿片类药物依赖和戒断对芬太尼、可卡因和甲基苯丙胺自我给药的影响,分别在注射吗啡后12小时或20小时进行实验。在阿片类药物戒断期间,芬太尼剂量反应曲线向右移动,最大效应增加,而在目前依赖阿片类药物的大鼠中评估时,相对于基线,曲线向右移动但最大效应降低。可卡因和甲基苯丙胺的强化作用在两种情况下均未改变。当前研究提供了直接证据,即相对于未产生身体依赖的大鼠,芬太尼在阿片类药物戒断的大鼠中的强化作用增强,而在阿片类药物依赖的大鼠中减弱。这些发现表明,使用阿片类药物的动机取决于个体状态,而兴奋剂无论个体处于阿片类药物依赖还是戒断状态,都保持其强化作用。